Noahsprent (Talk | contribs) |
Helenrensiyu (Talk | contribs) |
||
Line 142: | Line 142: | ||
<ul class="dropdown-menu"> | <ul class="dropdown-menu"> | ||
<li><a href="https://2017.igem.org/Team:Oxford/Model">Overview</a></li> | <li><a href="https://2017.igem.org/Team:Oxford/Model">Overview</a></li> | ||
− | <li><a href="https://2017.igem.org/Team:Oxford/Results_Dry_Lab">Results</a></li> | + | <!-- <li><a href="https://2017.igem.org/Team:Oxford/Results_Dry_Lab">Results</a></li> --> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<li><a href="https://2017.igem.org/Team:Oxford/DNA_Based_Model">DNA-Based Model</a></li> | <li><a href="https://2017.igem.org/Team:Oxford/DNA_Based_Model">DNA-Based Model</a></li> | ||
<li><a href="https://2017.igem.org/Team:Oxford/Protein_Based_Model">Protein-Based Model</a></li> | <li><a href="https://2017.igem.org/Team:Oxford/Protein_Based_Model">Protein-Based Model</a></li> | ||
+ | <!-- <li><a href="https://2017.igem.org/Team:Oxford/Cell_Free_Model">Cell-Free Model</a></li> --> | ||
+ | <!-- <li><a href="https://2017.igem.org/Team:Oxford/OMV_Model">OMV Model</a></li> --> | ||
+ | <li><a href="https://2017.igem.org/Team:Oxford/Disease_Model">Disease Model</a></li> | ||
+ | <li><a href="https://2017.igem.org/Team:Oxford/Software">Software</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 175: | Line 175: | ||
<li><a href="https://2017.igem.org/Team:Oxford/Attributions">Attributions</a></li> | <li><a href="https://2017.igem.org/Team:Oxford/Attributions">Attributions</a></li> | ||
<li><a href="https://2017.igem.org/Team:Oxford/Sponsors">Sponsors</a></li> | <li><a href="https://2017.igem.org/Team:Oxford/Sponsors">Sponsors</a></li> | ||
− | <li><a href="https://2017.igem.org/Team:Oxford/MedalRequirements">Our Medal | + | <li><a href="https://2017.igem.org/Team:Oxford/MedalRequirements">Our Medal Achievements</a></li> |
</ul> | </ul> | ||
</li> | </li> |
Revision as of 03:29, 2 November 2017